GlassScriptPhysician profile
William Earl Cunningham
NPI 1619157245
$984.91
in general payments reported to CMS, 2019-2025
16 companies · $55.00 in 2025
The $55.00 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.45 · 2020: $173 · 2021: $168 · 2022: $47.92 · 2023: $300 · 2024: $152 · 2025: $55.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $295.21 | 2019-2024 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $171.52 | 2023-2025 | Avvigo Guidance System |
| Lilly USA, LLC | $110.50 | 2023-2024 | Mounjaro, Trulicity |
| Merck Sharp & Dohme LLC | $81.65 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $78.47 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $41.49 | 2019 | |
| Esperion Therapeutics, INC. | $38.80 | 2020-2021 | |
| Exact Sciences Corporation | $30.44 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $24.06 | 2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.81 | 2021 | |
| Abbott Laboratories | $18.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.96 | 2023 | Xarelto |
| Currax Pharmaceuticals LLC | $15.40 | 2024 | Contrave |
| Bayer Healthcare Pharmaceuticals INC. | $15.35 | 2022 | |
| Pfizer INC. | $14.66 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.